Skip to main content
. 2019 Jul 16;4(4):668–673. doi: 10.1016/j.adro.2019.07.007

Table 2.

Baseline patient characteristics

Variable Total (n = 30)
Age at baseline 76.6 (61-89)
Clinical stage
 T1c 7 (23.3%)
 T2 17 (56.7%)
 T3 5 (16.7%)
 T4 1 (3.3%)
PSA at baseline 25.56 (6.58-98.4)
Gleason score
 6 4 (13.3%)
 7 9 (30.0%)
 8 9 (30.0%)
 9-10 8 (26.7%)
Risk category (based on NCCN criteria)
 High 23 (76.6%)
 Very high 7 (23.3%)

Abbreviations: NCCN = National Comprehensive Cancer Network; PSA = prostate-specific antigen.